Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer

Ian M Thompson, Joseph A. Basler, Robin Leach, Dean Troyer, Eric Klein, Otis Brawley

Producción científica: Articlerevisión exhaustiva

3 Citas (Scopus)

Resumen

Since 1991 and the activation of the Prostate Cancer Prevention Trial as well as similar prevention studies in several other organ sites, the interest in prostate cancer prevention has increased substantially. Despite such interest, the challenges to prevention trials-in design, implementation, prioritization, and allocation of resources-are substantial. Simultaneously, there has been an explosion in new targets and agents that may have an effect in the prevention of this disease. In this manuscript, we discuss these challenges to the study of prostate cancer prevention and provide a blueprint for prioritization of future studies.

Idioma originalEnglish (US)
Páginas (desde-hasta)73-78
Número de páginas6
PublicaciónUrologic Oncology: Seminars and Original Investigations
Volumen21
N.º1
DOI
EstadoPublished - ene 2003

ASJC Scopus subject areas

  • Urology
  • Oncology

Huella

Profundice en los temas de investigación de 'Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer'. En conjunto forman una huella única.

Citar esto